These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 24116869)
21. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545 [TBL] [Abstract][Full Text] [Related]
22. Mesoporous silica material TUD-1 as a drug delivery system. Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183 [TBL] [Abstract][Full Text] [Related]
23. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966 [TBL] [Abstract][Full Text] [Related]
24. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems. Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768 [TBL] [Abstract][Full Text] [Related]
25. Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs. Abioye AO; Kola-Mustapha A Pharm Res; 2015 Jun; 32(6):2110-31. PubMed ID: 25527142 [TBL] [Abstract][Full Text] [Related]
26. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers. Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833 [TBL] [Abstract][Full Text] [Related]
27. Tuning drug loading and release properties of diatom silica microparticles by surface modifications. Bariana M; Aw MS; Kurkuri M; Losic D Int J Pharm; 2013 Feb; 443(1-2):230-41. PubMed ID: 23287775 [TBL] [Abstract][Full Text] [Related]
28. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs. Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595 [TBL] [Abstract][Full Text] [Related]
29. Amine-modified SBA-15 and MCF mesoporous molecular sieves as promising sorbents for natural antioxidant. Modeling of caffeic acid adsorption. Moritz M; Geszke-Moritz M Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():411-21. PubMed ID: 26838867 [TBL] [Abstract][Full Text] [Related]
30. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Yang YJ; Tao X; Hou Q; Chen JF Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764 [TBL] [Abstract][Full Text] [Related]
31. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084 [TBL] [Abstract][Full Text] [Related]
32. pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery. Sousa CT; Nunes C; Proença MP; Leitão DC; Lima JL; Reis S; Araújo JP; Lúcio M Colloids Surf B Biointerfaces; 2012 Jun; 94():288-95. PubMed ID: 22366067 [TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release. Rehman F; Rahim A; Airoldi C; Volpe PLO Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of carboxyl-modified rod-like SBA-15 by rapid co-condensation. Shen S; Chow PS; Kim S; Zhu K; Tan RB J Colloid Interface Sci; 2008 May; 321(2):365-72. PubMed ID: 18328495 [TBL] [Abstract][Full Text] [Related]
36. Nanostructured SBA-15 host applied in ketorolac tromethamine release system. Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001 [TBL] [Abstract][Full Text] [Related]
37. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer. Zhang P; Wu T; Kong JL ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082 [TBL] [Abstract][Full Text] [Related]
38. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties. Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561 [TBL] [Abstract][Full Text] [Related]
39. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. Kapoor S; Hegde R; Bhattacharyya AJ J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029 [TBL] [Abstract][Full Text] [Related]
40. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release. Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]